Please use this identifier to cite or link to this item:
|Title:||Combination of tumor fragments and nanotechnology as a therapeutic approach: Treating a tumor with tumor||Authors:||Chen, X
|Issue Date:||1-Dec-2020||Publisher:||Elsevier BV||Citation:||Chen, X, Zhang, Y (2020-12-01). Combination of tumor fragments and nanotechnology as a therapeutic approach: Treating a tumor with tumor. Nano Today 35 : 100993-100993. ScholarBank@NUS Repository. https://doi.org/10.1016/j.nantod.2020.100993||Abstract:||Cancer with high mortality is a serious threat to human health. Thus, favorable approaches for efficient elimination of tumors are urgently needed. Recently, a new antitumor strategy of tumor-derived fragments (TDFs) interfered with nanotechnology has been developed for highly specific and efficient tumor therapy. On one hand, TDF-based nanoformulations (termed as TDF-NFs) and nanoparticle-induced immunogenic dying tumor cells (IDTCs) can act as ex situ/in situ vaccines to elicit the immune responses for cancer immunotherapy. On the other hand, TDF-NFs can be drug carriers for cancer theranostics. In this review, the immune regulation mechanisms of various TDFs including tumor-derived DNA/RNA, tumor cell membranes, tumor-derived exosomes, whole tumor lysates, and IDTCs are summarized, and the applications of nanotechnology-intervened TDFs as vaccines and vehicles in tumor therapy are also highlighted. It is hoped that the review will inspire researchers to further construct functional TDF-based nanovaccines and nanocarriers, facilitating the development of novel antitumor strategies.||Source Title:||Nano Today||URI:||https://scholarbank.nus.edu.sg/handle/10635/227577||ISSN:||1748-0132
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
|Manuscript-R1.pdf||Submitted version||7.44 MB||Adobe PDF|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.